Medicare Enrolled
Dr. Ahmad Sabouni, M.D.
Neurology · Lubbock, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sabouni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sabouni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sabouni
Dr. Ahmad Sabouni is a neurology specialist in Lubbock, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sabouni performed 80,701 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sabouni received a total of $65,323 from 80 pharmaceutical and/or device companies across 1539 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sabouni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in TX
$65,323 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗80,701
Medicare services
Top 1% in TX for neurology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Capsaicin pain patch (Qutenza) | 49,840 | $2 | $11 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
25,301 | $5 | $12 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,641 | $45 | $112 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,258 | $84 | $234 |
| Rimabotulinumtoxinb injection, 100 units An injection of rimabotulinumtoxinb administered in a dose of 100 units. |
775 | $10 | $23 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
425 | $116 | $302 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
297 | $46 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
176 | $60 | $165 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
122 | $46 | $121 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
81 | $127 | $343 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
74 | $107 | $325 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
74 | $48 | $130 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
65 | $194 | $350 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
64 | $70 | $186 |
| Video EEG monitoring, 2-12 hours Continuous monitoring of brain wave activity combined with video recording for a duration of 2 to 12 hours. |
59 | $482 | $1,198 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
59 | $98 | $246 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
54 | $35 | $84 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
47 | $74 | $350 |
| Destruction of peripheral nerve or branch | 47 | $254 | $464 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 40 | $175 | $363 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
35 | $115 | $350 |
| Chemical paralysis of salivary glands, bilateral Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth. |
32 | $95 | $270 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
29 | $34 | $92 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
25 | $189 | $477 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
21 | $200 | $554 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $159 | $412 |
| New patient office visit, complex (60-74 min) | 16 | $150 | $399 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $127 | $327 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $85 | $202 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
32.8% medium
67.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$65,323
Total received (2018-2024)
Avg $9,332/year across 7 years
Top 8% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,539
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,923
2023
$3,911
2022
$10,650
2021
$38,060
2020
$3,376
2019
$2,656
2018
$2,747
Payments by company (2024)
ABBVIE INC.
$555
REVANCE THERAPEUTICS, INC.
$302
TG Therapeutics, Inc.
$253
Eisai Inc.
$236
UCB, Inc.
$229
EMD Serono, Inc.
$226
Amgen Inc.
$210
Teva Pharmaceuticals USA, Inc.
$204
Lilly USA, LLC
$190
Neurocrine Biosciences, Inc.
$178
Abbott Laboratories
$160
PFIZER INC.
$158
Merz Pharmaceuticals, LLC
$140
SK Life Science, Inc.
$124
ARGENX US, INC.
$108
Alexion Pharmaceuticals, Inc.
$86
JAZZ PHARMACEUTICALS INC.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$51
Amneal Pharmaceuticals LLC
$51
Genentech USA, Inc.
$50
Vanda Pharmaceuticals Inc.
$50
Medtronic, Inc.
$42
Biogen, Inc.
$41
Acorda Therapeutics, Inc
$36
Novartis Pharmaceuticals Corporation
$33
Ipsen Biopharmaceuticals, Inc
$32
MDD US Operations, LLC
$32
Averitas Pharma Inc.
$28
Celgene Corporation
$27
Lundbeck LLC
$23
Amylyx Pharmaceuticals, Inc.
$15
Top 3 companies account for 28.3% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$25,060
Biogen, Inc.
$10,886
ABBVIE INC.
$7,881
Allergan, Inc.
$2,224
Teva Pharmaceuticals USA, Inc.
$1,943
Supernus Pharmaceuticals, Inc.
$1,519
Neurocrine Biosciences, Inc.
$1,113
Amgen Inc.
$928
EMD Serono, Inc.
$915
Novartis Pharmaceuticals Corporation
$805
UCB, Inc.
$759
Lilly USA, LLC
$654
GENZYME CORPORATION
$561
ACADIA Pharmaceuticals Inc
$514
Lundbeck LLC
$489
SK Life Science, Inc.
$463
Alexion Pharmaceuticals, Inc.
$457
Allergan Inc.
$421
Sunovion Pharmaceuticals Inc.
$408
Acorda Therapeutics, Inc
$372
Biohaven Pharmaceutical Holding Company Ltd.
$365
PFIZER INC.
$323
Abbott Laboratories
$321
Genentech USA, Inc.
$316
Kyowa Kirin, Inc.
$304
REVANCE THERAPEUTICS, INC.
$302
Amneal Pharmaceuticals LLC
$294
Merz Pharmaceuticals, LLC
$278
ARGENX US, INC.
$259
TG Therapeutics, Inc.
$253
US WorldMeds, LLC
$249
Harmony Biosciences LLC
$248
Eisai Inc.
$236
Adamas Pharmaceuticals, Inc.
$211
GRT US Holding, Inc.
$198
Amylyx Pharmaceuticals, Inc.
$191
LivaNova USA, Inc.
$184
Avanir Pharmaceuticals, Inc.
$169
Celgene Corporation
$160
Upsher-Smith Laboratories LLC
$156
Horizon Therapeutics plc
$146
Ipsen Biopharmaceuticals, Inc
$143
Takeda Pharmaceuticals U.S.A., Inc.
$131
MITSUBISHI TANABE PHARMA AMERICA, INC.
$118
Medtronic, Inc.
$106
UPSHER-SMITH LABORATORIES LLC
$85
JAZZ PHARMACEUTICALS INC.
$71
Greenwich Biosciences, Inc.
$70
Akcea Therapeutics, Inc.
$64
Biohaven Pharmaceuticals, Inc.
$63
TG THERAPEUTICS, INC.
$61
Medtronic USA, Inc.
$61
E.R. Squibb & Sons, L.L.C.
$58
GE HEALTHCARE
$55
Chiesi USA, Inc.
$50
Vanda Pharmaceuticals Inc.
$50
Averitas Pharma Inc.
$42
GE HealthCare
$37
Neurelis, Inc.
$36
Alnylam Pharmaceuticals Inc.
$32
MDD US Operations, LLC
$32
Mallinckrodt Enterprises LLC
$32
Otsuka America Pharmaceutical, Inc.
$31
AbbVie, Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$31
CSL Behring
$31
Grifols USA, LLC
$28
Merz North America, Inc.
$27
Assertio Therapeutics, Inc.
$24
NS Pharma, Inc.
$23
CATALYST PHARMACEUTICALS, INC.
$20
Zogenix Inc.
$20
Alfasigma USA, Inc.
$19
Mallinckrodt LLC
$18
Exeltis, USA Inc.
$17
Janssen Pharmaceuticals, Inc
$15
Octapharma USA, Inc.
$15
Strongbridge US INC.
$15
Genentech, Inc.
$14
Impax Laboratories, Inc.
$13
Top 3 companies account for 67.1% of all-time payments
Associated products mentioned in payments ›
ABSOLUTE PRO · ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · CLEVIPREX · COMIRNATY · COPAXONE · DAXXIFY · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · EPIDIOLEX · EVENITY · Epidiolex · FIRDAPSE · Fintepla · GAMMAGARD · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SenSight · Skyclarys · Soliris · TAVNEOS · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VILTEPSO · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
7
County median income
$63,367
Nearest hospital to ZIP centroid (approximate)
COVENANT MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sabouni is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sabouni experienced with capsaicin pain patch (qutenza)?
Based on Medicare claims data, Dr. Sabouni performed 49,840 capsaicin pain patch (qutenza) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sabouni receive payments from pharmaceutical companies?
Yes. Dr. Sabouni received a total of $65,323 from 80 companies across 1,539 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sabouni's costs compare to other neurologists in Lubbock?
Dr. Sabouni's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sabouni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Lubbock
Browse neurologists in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology